Survival disparities between black and white women are largely explained by differing presentation characteristics at diagnosis.
To better understand why black women have poorer breast cancer outcomes than white women, investigators analyzed Surveillance, Epidemiology and End Results (SEER)–Medicare data from 7400 black women and 100,000 white women with breast cancer diagnoses between 1991 and 2005. Women were matched in three sets based on demographics (age, year of diagnosis, and SEER site), presentation (comorbidities and tumor biology), and treatment.
The demographics match showed that 5-year survival was 12.9% lower among black women than white women. This difference was 4.4% when presentation characteristics were added to the match and 3.6% when treatment was added. Treatment differences accounted for only 0.8% of the 12.9% survival disparity; however, the inte…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)